Inovio prices public offering at approximately $75 million
INO•Inovio Pharmaceuticals priced a public offering expected to raise approximately $75 million gross, excluding any underwriters’ option exercise. It includes 58,747,235 shares at $1.05 each and pre-funded warrants for 12,681,337 shares at $1.049 each.
1. Offering details
Inovio Pharmaceuticals priced a public offering expected to raise approximately $75 million gross, excluding any exercise of the underwriters’ option. The offering includes 58,747,235 common shares at $1.05 each and pre-funded warrants to purchase 12,681,337 common shares at $1.049 each, before underwriting discounts and commissions.
2. Closing and option
Underwriters have a 30-day option to purchase 10,714,285 additional common shares at the offering price, less underwriting discounts and commissions. The offering is expected to close on or about November 9, 2026, subject to customary closing conditions.
